bromopyruvic acid glutathione 3-Bromopyruvic (Bromopyruvic acid) | Hexokinase II Inhibitor The promising anticancer drug 3-bromopyruvate
The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect 3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy Induction of Ferroptosis by Dual Targeting pH Responsive Nanomicelles in the Treatment of Tamoxifen Resistant Breast Cancer ACS Applied Nano Materials Reaction schemes of nucleophilic substitution of the thiolate anion of Download Scientific Diagram
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



